OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
482680$2030.0056

Mirae Asset Vision Special Purpose Acquisition 7 Co

Investment Holding CompaniesVerified

Mirae Asset Vision Special Purpose Acquisition 7 Co maintains a strong liquidity position, with cash and equivalents amounting to KRW 3.78 billion, representing 18.7% of total assets. The company's liquidity FPT (free cash flow to price) is robust, supported by a current ratio of 20,234.55, indicating minimal short-term liquidity risk. The price-to-book ratio is 1.0, suggesting the market value aligns with the book value of equity. Profitability metrics are limited due to the SPAC's pre-merger status, with net income of KRW 260.8 million and operating income of KRW -38.0 million. Return on equity (ROE) is 1.56%, and return on assets (ROA) is 1.29%, both below the typical thresholds for active operating companies. The company's debt-to-equity ratio is 0.2, indicating a conservative capital structure with low leverage. The company's revenue is currently zero, as it is in the pre-merger phase. Revenue concentration is not applicable at this stage, as the company has no disclosed operating segments or geographic revenue breakdown. The SPAC is expected to target a range of industries, including renewable energy, biopharmaceuticals, and green transportation, as outlined in its prospectus. Outlook for the current fiscal year is neutral, with no revenue growth expected. The company is in the process of identifying a merger target, and the next fiscal year's performance will depend on the success of the acquisition. The company's free cash flow of KRW 260.8 million supports its liquidity position during the pre-merger phase. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's capital structure is stable, with a low debt-to-equity ratio and no near-term dilution pressure. The absence of operating revenue and the speculative nature of SPACs introduce uncertainty, but the company's strong cash position mitigates some of these risks. Recent events include the company's continued search for a merger target, with no material changes in its financial position. The company has not issued any new shares or taken on additional debt, maintaining a stable capital structure. No significant regulatory or legal issues have been reported in recent filings.

30-day price · 482680+15.00 (+0.7%)
Low$2020.00High$2065.00Close$2055.00As of25 May, 00:00 UTC
Profile
CompanyMirae Asset Vision Special Purpose Acquisition 7 Co
Ticker482680.KQ
SectorFinancials
BusinessInvestment Holding Companies
Industry groupInvestment Holding Companies
IndustryInvestment Holding Companies
AI analysis

Business. Mirae Asset Vision Special Purpose Acquisition 7 Co is a Korea-based special purpose acquisition company (SPAC) formed for the sole purpose of merging with existing corporations in sectors including renewable energy, biopharmaceuticals, IT convergence, and green transportation.

Classification. Mirae Asset Vision Special Purpose Acquisition 7 Co is classified under the Financials sector, specifically in the Investment Holding Companies industry, with a confidence level of 0.92.

Mirae Asset Vision Special Purpose Acquisition 7 Co maintains a strong liquidity position, with cash and equivalents amounting to KRW 3.78 billion, representing 18.7% of total assets. The company's liquidity FPT (free cash flow to price) is robust, supported by a current ratio of 20,234.55, indicating minimal short-term liquidity risk. The price-to-book ratio is 1.0, suggesting the market value aligns with the book value of equity. Profitability metrics are limited due to the SPAC's pre-merger status, with net income of KRW 260.8 million and operating income of KRW -38.0 million. Return on equity (ROE) is 1.56%, and return on assets (ROA) is 1.29%, both below the typical thresholds for active operating companies. The company's debt-to-equity ratio is 0.2, indicating a conservative capital structure with low leverage. The company's revenue is currently zero, as it is in the pre-merger phase. Revenue concentration is not applicable at this stage, as the company has no disclosed operating segments or geographic revenue breakdown. The SPAC is expected to target a range of industries, including renewable energy, biopharmaceuticals, and green transportation, as outlined in its prospectus. Outlook for the current fiscal year is neutral, with no revenue growth expected. The company is in the process of identifying a merger target, and the next fiscal year's performance will depend on the success of the acquisition. The company's free cash flow of KRW 260.8 million supports its liquidity position during the pre-merger phase. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's capital structure is stable, with a low debt-to-equity ratio and no near-term dilution pressure. The absence of operating revenue and the speculative nature of SPACs introduce uncertainty, but the company's strong cash position mitigates some of these risks. Recent events include the company's continued search for a merger target, with no material changes in its financial position. The company has not issued any new shares or taken on additional debt, maintaining a stable capital structure. No significant regulatory or legal issues have been reported in recent filings.
Key takeaways
  • The company maintains a strong liquidity position with a current ratio of 20,234.55 and KRW 3.78 billion in cash and equivalents.
  • Net income of KRW 260.8 million and a price-to-book ratio of 1.0 suggest the company is valued in line with its book value.
  • The company has no operating revenue and is in the pre-merger phase, with performance dependent on the success of a future acquisition.
  • Low liquidity and dilution risk, with no immediate filing-based flags detected.
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.2 and no near-term dilution pressure.
  • The company is actively seeking a merger target in sectors such as renewable energy, biopharmaceuticals, and green transportation.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$0.00
Gross profit
Operating income-$38.0M
Net income$260.8M
R&D
SG&A
D&A
SBC
Operating cash flow$398.4M
CapEx
Free cash flow$260.8M
Total assets$20.23B
Total liabilities$3.49B
Total equity$16.74B
Cash & equivalents$3.78B
Long-term debt$3.36B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$0.00-$38.0M$260.8M$260.8M
FY-1$0.00-$26.0M$44.0M$44.0M
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$20.23B$16.74B$3.78B
FY-1$19.88B$16.49B$3.81B
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0$398.4M$260.8M
FY-1-$23.9M$44.0M
FY-2
FY-3$0.00
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$0.00-$4.4M$51.6M
FQ-1$0.00-$3.9M$81.9M$81.9M
FQ-2$0.00-$19.4M$61.0M$61.0M
FQ-3$0.00-$10.3M$66.4M$66.4M
FQ-4$0.00-$4.4M$74.2M
FQ-5$0.00-$7.0M-$4.3M-$4.3M
FQ-6-$25.9M
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$20.23B$16.74B$3.78B
FQ-1$20.14B$16.70B$3.78B
FQ-2$20.10B$16.62B$3.79B
FQ-3$19.99B$16.56B$3.80B
FQ-4$19.88B$16.49B$3.81B
FQ-5$19.75B$16.42B$3.82B
FQ-6$4.08B$778.5M$4.08B
FQ-7
PeriodOCFCapExFCFSBC
FQ0$398.4M
FQ-1$401.2M$81.9M
FQ-2-$27.7M$61.0M
FQ-3-$10.3M$66.4M
FQ-4-$23.9M
FQ-5-$21.1M-$4.3M
FQ-6-$14.1M-$25.9M
FQ-7
Valuation
Market price$2030.00
Market cap$16.68B
Enterprise value$16.26B
P/E64.0
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF40.8
P/B1.0
P/Tangible book1.0
Tangible book$16.74B
Net cash$418.9M
Current ratio20234.5
Debt/Equity0.2
ROA1.3%
ROE1.6%
Cash conversion1.5%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Investment Holding Companies · cohort 83 companies
Metric482680Activity
Op margin6.3% medp25 -13.7% · p75 66.3%
Net margin8.8% medp25 -0.8% · p75 71.1%
Gross margin40.1% medp25 27.9% · p75 68.1%
CapEx / revenue-3.7% medp25 -14.6% · p75 -0.9%
Debt / equity20.0%0.0% medp25 0.0% · p75 3.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 00:41 UTC#c0c22c44
Market quoteclose KRW 2030.00 · shares 0.01B diluted
no public URL
2026-05-05 00:41 UTC#916941fa
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 00:42 UTCJob: ecd67dcc